Finance

Lists
Why is CTY up 10.57%?
Dive Deeper
CTY:NASDAQ
City Therapeutics, Inc.
$20.29
+10.57%
(+1.94) 1D
Nov 20, 11:12:17 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTY...
Open
$18.35
High
$20.29
Low
$16.96
Mkt. cap
1.08B
Avg. vol.
276.71K
Volume
60.91K
52-wk high
$23.88
52-wk low
$15.81
EPS
-$1.76
No. of employees
75
Open
$18.35
High
$20.29
Low
$16.96
Mkt. cap
1.08B
Avg. vol.
276.71K
Volume
60.91K
52-wk high
$23.88
52-wk low
$15.81
EPS
-$1.76
No. of employees
75
News stories
From web sources and news partners
About City Therapeutics, Inc.
CEO-
Employees75
Founded2023
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecitytx.com
Analyst ratings
Based on 2 analysts giving stock ratings to CTY in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CTY in the last 3 months.
Highest
Current $20.29
$34.00 (+67.57%)
Average
$33.00 (+62.64%)
Lowest
$32.00 (+57.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Initiated
$34.00
+67.6%
11/10/2026
Maury Raycroft
Jefferies
Buy
Initiated
$32.00
+57.7%
11/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
2.79M
2.79M
3.18M
3.18M
Cost of goods sold
12.19M
12.19M
23.16M
23.16M
Cost of revenue
12.19M
12.19M
23.16M
23.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.90M
3.90M
5.58M
5.58M
Operating expense
3.90M
3.90M
5.58M
5.58M
Total operating expenses
16.09M
16.09M
28.74M
28.74M
Operating income
-13.30M
-13.30M
-25.57M
-25.57M
Other non operating income
-65.50K
-65.50K
-1.21M
-1.21M
EBT including unusual items
-12.14M
-12.14M
-26.72M
-26.72M
EBT excluding unusual items
-12.65M
-12.65M
-26.72M
-26.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.14M
-12.14M
-26.72M
-26.72M
Net profit margin
-435.32%
-435.32%
-840.56%
-840.56%
Earnings per share
-
-
-
-
Interest and investment income
1.03M
1.03M
797.50K
797.50K
Interest expense
-323.00K
-323.00K
-748.00K
-748.00K
Net interest expenses
709.00K
709.00K
49.50K
49.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.04M
-13.04M
-25.16M
-25.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps